FDA Inspection 1032404 — Stryker Neurovascular
The FDA completed an inspection of Stryker Neurovascular on September 22, 2017 in Fremont, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 22, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Fremont, CA (United States)
Additional Details
Sponsor, Contract Research Organization